The COVID-19 pandemic has upended much of the global economy. While most individual's lives have been disrupted, we are still seeing tremendous progress in the scientific community to research this virus and ultimately create a vaccine. As a provider of primary cells to researchers around the world, Cell Systems is ready to ship cells, media and reagents to enable valuable research to continue. Though the insights surrounding this virus are still in the early stage, there has been some interesting papers surrounding COVID-19 and vascular biology -- particularly endothelial cells, including this one in The Lancet. Cell Systems has a large...
In gene therapy and pharmacology, the blood brain barrier (BBB) is a known obstacle prohibiting efficient drug transport to the CNS. One step to unlocking this black box is the creation of an in vitro human BBB model. In the link below, read on to see how scientists used ACBRI 376 cells (Primary Human Brain Microvascular Endothelial Cells) to create a 3D vascular model of CNS angiogenesis. Cell Systems antibody free Primary Human Brain Microvascular Endothelial Cells are ideal tools for your cell biology research. Cell Systems ships globally from an inventory that allows for primary cells to always be...
Primary Cells in Action: a co-culture system based solely on the use of human induced pluripotent stem cell (hiPSC)-derived cells. For the first time, hiPSC-derived retinal pigment epithelium (RPE) and endothelial cells (EC) were cultured on opposite sides of porous polylactide substrates prepared by breath figures (BF), where both surfaces had been collagen-coated by Langmuir-Schaefer (LS) technology.
Read more here:
To purchase our Human Primary Retinal Microvascular Endothelial Cells (ACBRI 181), visit the product page here:
Cell Systems primary cells and specialized media are valuable tools to the field of ophthalmology research. Investigate current research using our ACBRI 181 Primary Human Retinal Endothelial Cells and our specialized Normal Blood Glucose Media (4N0-500).